# Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.

> **NCT03254420** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 74 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Calypso beacon implant
- **RADIATION:** moderate hypofractionation Radiotherapy

## Key facts

- **NCT ID:** NCT03254420
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-08-30
- **Primary completion:** 2022-09-15
- **Final completion:** 2028-12
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2026-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03254420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03254420, "Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03254420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*